PDCD1 and head and neck squamous cell carcinoma: This prospective study evaluated 34 patients with initially unresectable, recurrent/metastatic HNSCC to examine whether chemotherapy response could be predicted using CTC, cCSC, and peripheral lymphocyte expression of PD-1.